top glp-1 medications for weight loss 2025 The FDA recently approved the first oral #GLP-1 receptor agonist indicated obesity. How does oral semaglutide stack up against the injection in terms of cost, dosing, and adverse effects? Find out Top Obesity and Diabetes Medications

Patients taking Zepbound may develop shortness of breath from unrelated conditions such as respiratory infections, cardiac issues, pulmonary embolism, or anxiety

Facile Functionalization of Gold Nanoparticles with PLGA Polymer Brushes and Efficient Encapsulation into PLGA Nanoparticles: Toward Spatially Precise Bioimaging of Polymeric Nanoparticles

The FDA has long turned a wary eye to the supplement industrys unverified claims but stopped short of serious reform

Plaintiffs allege that Novo Nordisk failed to warn about the risk of sudden and irreversible vision damage associated with its GLP-1 receptor agonist drugs

Its often used by those concerned about long-term brain health or recovering from neurological damage

Small exploratory cohorts suggest that baseline microbiota composition may correlate with differential metabolic response, giving rise to the responder/non-responder framework